Voloridge Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,846
Closed -$347K 1230
2023
Q3
$347K Sell
2,846
-39,510
-93% -$5.26M ﹤0.01% 1260
2023
Q2
$5.95M Sell
42,356
-109,017
-72% -$15M 0.03% 609
2023
Q1
$21.4M Buy
151,373
+143,982
+1,948% +$20.6M 0.11% 272
2022
Q4
$1.16M Buy
+7,391
New +$1.06M 0.01% 1106
2022
Q2
Sell
-67,971
Closed -$9.3M 1469
2022
Q1
$9.3M Sell
67,971
-78,547
-54% -$10.9M 0.05% 432
2021
Q4
$25.3M Buy
146,518
+88,655
+153% +$13.5M 0.14% 190
2021
Q3
$8.41M Buy
57,863
+42,289
+272% +$6.19M 0.05% 490
2021
Q2
$2.06M Sell
15,574
-299,292
-95% -$39.2M 0.01% 983
2021
Q1
$40.4M Buy
314,866
+180,604
+135% +$22.3M 0.3% 70
2020
Q4
$16M Buy
+134,262
New +$16.4M 0.13% 184
2020
Q2
Sell
-29,747
Closed -$2.39M 1305
2020
Q1
$2.39M Sell
29,747
-97,549
-77% -$10.1M 0.07% 308
2019
Q4
$13.6M Buy
127,296
+123,896
+3,644% +$12.9M 0.27% 82
2019
Q3
$364K Buy
+3,400
New +$349K 0.01% 878
2017
Q1
Sell
-144,229
Closed -$13.3M 525
2016
Q4
$13.3M Buy
144,229
+112,789
+359% +$9.72M 0.28% 89
2016
Q3
$2.66M Sell
31,440
-13,254
-30% -$1.11M 0.06% 140
2016
Q2
$3.64M Buy
+44,694
New +$3.4M 0.1% 159
2015
Q3
Sell
-51,817
Closed -$3.76M 308
2015
Q2
$3.76M Buy
+51,817
New +$3.83M 0.19% 126

Other funds holding DGX

Voloridge Investment Management's DGX Position: Q4 2023 in Review

Voloridge Investment Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,846 shares — an estimated $347K sold.

Voloridge Investment Management first reported a position in DGX in Q2 2015 and held it in 17 quarters. The position peaked at $40.4M in Q1 2021. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Voloridge Investment Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 2,846 Quest Diagnostics shares in Q4 2023, an estimated $347K.
  • Voloridge Investment Management first reported a position in Quest Diagnostics in Q2 2015 and held it in 17 quarters.
  • Voloridge Investment Management's Quest Diagnostics position peaked at $40.4M in Q1 2021.
  • 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.